Department of Clinical Pharmacy, Huzhou Central Hospital, Huzhou, China.
Department of Clinical Laboratory, Huzhou Central Hospital, Huzhou, China.
Pain Res Manag. 2022 Jul 8;2022:1119014. doi: 10.1155/2022/1119014. eCollection 2022.
The incidence of cancer is increasing worldwide on a yearly basis, with the number of patients with bone metastases also increasing annually. Events associated with bone metastases can seriously affect patient quality of life, through pain, hypercalcemia, bone marrow regeneration disorders, and spinal cord compression. In this nonrandomized controlled clinical trial study, we focused on the relationship between bone metastasis, pain, and cytokines before and after radiotherapy. We hypothesized that radiotherapy alters the cytokine profile of the local bone environment. Combined with the analgesic effects of radiotherapy, certain cytokines may be very sensitive to radiation. External radiation therapy is commonly used to treat cancer patients with bone metastases and can effectively relieve metastasis-related pain, although its underlying mechanisms have not been fully elucidated. For this case-control study, we recruited 30 cancer patients with bone metastasis and 30 healthy individuals. Peripheral venous blood from healthy individuals was collected. The clinical characteristics and peripheral venous blood were collected from patients one week before and one week after radiotherapy. The preradiotherapy and postradiotherapy pain scores, quality of life (QOL), and blood cytokine profiles of the patients to that of the controls were collected to identify pain-related cytokines. Finally, the pain score and the quality of life score improved significantly after radiotherapy. Moreover, the preradiotherapy and postradiotherapy blood cytokine profiles of the patients showed significant differences, indicating that the analgesic effect of radiotherapy against bone metastases is mediated via altered cytokine production. Furthermore, some cytokines were more sensitive to radiotherapy. The levels of MIP-1, MCP-2, TIMP-1, RANTES, IGFBP3, and TNF- showed significant differences in the pairwise comparative analysis and may therefore mediate pain associated with bone metastasis.
全球范围内癌症的发病率逐年上升,伴发骨转移的患者人数也逐年增加。骨转移相关事件可严重影响患者的生活质量,导致疼痛、高钙血症、骨髓再生障碍和脊髓压迫等。在这项非随机对照临床试验研究中,我们重点关注了骨转移、疼痛和细胞因子在放疗前后的关系。我们假设放疗改变了局部骨环境中的细胞因子谱。某些细胞因子可能对辐射非常敏感,结合放疗的镇痛作用。放射治疗通常用于治疗伴有骨转移的癌症患者,可有效缓解转移相关性疼痛,尽管其潜在机制尚未完全阐明。对于本病例对照研究,我们招募了 30 名伴有骨转移的癌症患者和 30 名健康个体。采集健康个体的外周静脉血。在放疗前一周和放疗后一周收集患者的临床特征和外周静脉血。收集患者放疗前后的疼痛评分、生活质量(QOL)和血液细胞因子谱与对照组进行比较,以确定与疼痛相关的细胞因子。最后,放疗后疼痛评分和生活质量评分显著改善。此外,患者放疗前后的血液细胞因子谱显示出显著差异,表明放射治疗对骨转移的镇痛作用是通过改变细胞因子的产生来介导的。此外,某些细胞因子对放疗更敏感。MIP-1、MCP-2、TIMP-1、RANTES、IGFBP3 和 TNF-α 在两两比较分析中差异有统计学意义,因此可能介导与骨转移相关的疼痛。